Shares of Owens & Minor, Inc. (NYSE:OMI) have received a consensus recommendation of “Hold” from five financial analysts currently covering the stock, according to Marketbeat. The average 12-month target price is set at $11.60, reflecting a mix of optimism and caution among market experts.
Among the ratings, one analyst has issued a sell recommendation, while two analysts suggest holding the stock, and two have rated it as a buy. Notably, Citigroup recently lowered its price target from $13.00 to $11.00 but maintained a “buy” rating in a report dated April 17, 2023. In a separate analysis, Robert W. Baird increased its target from $9.00 to $10.00, assigning a “neutral” rating on June 6, 2023.
Owens & Minor’s Financial Performance
On May 10, 2023, Owens & Minor released its quarterly earnings, reporting an earnings per share (EPS) of $0.23. This figure exceeded analysts’ expectations of $0.20 by $0.03. The company achieved a positive return on equity of 17.09%, although it faced a net margin of -3.41%. Year-over-year, the company’s quarterly revenue increased by 0.7%.
As of Wednesday, shares of Owens & Minor opened at $8.12. The company has a market capitalization of $627.27 million and a price-to-earnings ratio of -1.71. Other financial metrics include a P/E/G ratio of 0.36 and a beta of 1.40. The stock has fluctuated within a 52-week range, hitting a low of $6.07 and a high of $16.98.
Company Overview and Future Outlook
Owens & Minor operates as a healthcare solutions company, focusing on product manufacturing, delivery services, home health supply, and perioperative services. Its operations are divided into Products and Healthcare Services, and Patient Direct segments. Analysts project that the company will post an EPS of 1.51 for the current fiscal year.
Investors and analysts alike are monitoring Owens & Minor’s performance closely, particularly in light of recent adjustments in price targets and earnings results. As the company navigates the complexities of the healthcare market, its ability to achieve anticipated earnings will be crucial for maintaining investor confidence.
